2,4-thiazolidinedione has been researched along with Blood Pressure, High in 9 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both metformin and thiazolidinedione derivatives(TZDs) improve insulin resistance, a major pathogenesis of type 2 diabetes, and decrease blood glucose levels without stimulating insulin secretion." | 4.82 | [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives]. ( Satoh, J, 2003) |
| "For now, the goals and methods of treating hypertension and dyslipidemia are the same in people with the metabolic syndrome as in the general population." | 2.41 | A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. ( Hoogwerf, BJ; Nambi, V; Sprecher, DL, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ketsawatsomkron, P | 1 |
| Pelham, CJ | 1 |
| Groh, S | 1 |
| Keen, HL | 1 |
| Faraci, FM | 1 |
| Sigmund, CD | 1 |
| Mori, S | 1 |
| Tyagi, S | 1 |
| Sharma, S | 1 |
| Budhiraja, RD | 1 |
| Nambi, V | 1 |
| Hoogwerf, BJ | 1 |
| Sprecher, DL | 1 |
| Gurnell, M | 1 |
| Savage, DB | 1 |
| Chatterjee, VK | 1 |
| O'Rahilly, S | 1 |
| Satoh, J | 1 |
| Wolffenbuttel, BH | 1 |
| van Haeften, TW | 1 |
| Kasuga, M | 1 |
| Hunabiki, A | 1 |
| Morita, S | 1 |
| Medina, G | 1 |
| Sewter, C | 1 |
| Puig, AJ | 1 |
8 reviews available for 2,4-thiazolidinedione and Blood Pressure, High
| Article | Year |
|---|---|
Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature?
Topics: Animals; Blood Pressure; Endothelium, Vascular; Genes, Dominant; Humans; Hypertension; Insulin Resis | 2010 |
[Pharmacotherapy of osteoporosis accompanied by lifestyle-related diseases].
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Diseases; Diabetes Complications; Diphosphonate | 2011 |
A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hyperinsulinism; Hypertension; Hypertrigly | 2002 |
The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation.
Topics: Adipose Tissue; Animals; Arteriosclerosis; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agent | 2003 |
[Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
Topics: Adipocytes; Adiponectin; Cyclic AMP-Dependent Protein Kinases; Diabetes Complications; Diabetes Mell | 2003 |
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Topics: Acarbose; Aldehyde Reductase; Biguanides; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hy | 1995 |
[Etiology and therapy of insulin resistance].
Topics: Animals; Arteriosclerosis; Biguanides; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertens | 1999 |
[PPARgamma and thiazolidinediones, something more than a treatment for diabetes].
Topics: Arteriosclerosis; Cell Differentiation; Cell Transformation, Neoplastic; Diabetes Mellitus, Type 2; | 2000 |
1 other study available for 2,4-thiazolidinedione and Blood Pressure, High
| Article | Year |
|---|---|
Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Atorvastatin; Blood Pressure; Desoxycorticosterone; Endothe | 2012 |